about
Drug company-sponsored patient assistance programs: a viable safety net?Childhood maltreatment, juvenile disorders and adult post-traumatic stress disorder: a prospective investigation.Measuring quality of care for rheumatic diseases using an electronic medical recordGlobalization and eating disorder risk: peer influence, perceived social norms, and adolescent disordered eating in Fiji.State generic substitution laws can lower drug outlays under Medicaid.Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women's Health Initiative Memory Study.Early Childhood IQ Trajectories in Individuals Later Developing Schizophrenia and Affective Psychoses in the New England Family Studies.Posttraumatic stress disorder and incidence of type 2 diabetes mellitus in a sample of women: a 22-year longitudinal studyNeuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family StudiesPast horrors, present struggles: the role of stigma in the association between war experiences and psychosocial adjustment among former child soldiers in Sierra Leone.Development of a measure of "acculturation" for ethnic Fijians: methodologic and conceptual considerations for application to eating disorders researchSchistosomiasis haematobium prevalence and risk factors in a school-age population of peri-urban Lusaka, Zambia.Knowledge base and caretaker-child communication about HIV in peri-urban schoolchildren of Lusaka, Zambia.The variability and quality of medication container labels.Attachment style and coping in relation to posttraumatic stress disorder symptoms among adults living with HIV/AIDS.Patient Assistance Programs: Information Is Not Our EnemyAssociations between ADHD and emotional problems from childhood to young adulthood: a longitudinal genetically sensitive studyAre changes in ADHD course reflected in differences in IQ and executive functioning from childhood to young adulthood?
P50
Q33864928-BC8D8011-0491-4F86-9F2A-B13118258707Q33935028-B034DFDD-B01C-42DC-BB36-F04823860C6BQ34076204-CF4262B0-B336-4CB3-9FA7-775770885D09Q34415949-2075459E-884B-4703-BEBE-FE95DA5B45A1Q35010316-57899C9D-971E-4503-93E6-7BC88E16D1E8Q35034379-3457D643-A915-467F-A8E6-A20C2F6B2E70Q35739014-02855BED-D22F-4773-8A1C-9DB87CC64DBAQ35910565-080BE55D-F4C7-4179-9472-EB0A9C37EB09Q36929577-900B5FE6-15B0-4A15-9315-307B93DA4A18Q37131545-2EB79450-62F9-4C8A-9ED9-5EA3DE4E9E2BQ37187565-EF026103-398F-49B2-8DF6-5BF8D6AA7791Q39906668-EFFF6F2A-3331-4B2F-BA8A-07923A1FFEB6Q39969451-2FACCE1A-1374-493C-948F-2DF442B321DAQ44109777-DB62D122-425B-45F2-AC42-FFEF8464B4D0Q45983022-08B382B2-3F02-4B08-B428-F077B281D8C8Q59569633-1B1B70AB-53E1-4BB9-94F4-210F6B04A917Q89950926-2F714104-8F2A-476C-BC01-08FA32035A6DQ91257696-6F740C95-2D06-4F47-B71B-16B877E307FC
P50
description
researcher ORCID ID = 0000-0002-0755-6867
@en
wetenschapper
@nl
name
Jessica Agnew-Blais
@ast
Jessica Agnew-Blais
@en
Jessica Agnew-Blais
@es
Jessica Agnew-Blais
@nl
type
label
Jessica Agnew-Blais
@ast
Jessica Agnew-Blais
@en
Jessica Agnew-Blais
@es
Jessica Agnew-Blais
@nl
prefLabel
Jessica Agnew-Blais
@ast
Jessica Agnew-Blais
@en
Jessica Agnew-Blais
@es
Jessica Agnew-Blais
@nl
P106
P1153
21738936300
P21
P31
P496
0000-0002-0755-6867